Back

Ablation of ventricular tachycardia using computed tomography inHEART three-dimensional cardiac model

30 March 2025 (15:30 - 16:15)
Organised by: Logo
Congress Presentation Part of: Invasive treatment of ventricular arrhythmias Catheter Ablation of Arrhythmias EHRA Premium Access EHRA 2025 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Andrija Nekic

University Hospital Centre Zagreb, Zagreb (Croatia)

6 More presentations in this session

Presentation thumbnail
Three-dimensional cardiac CT integration for procedural guidance in LVOT-PVC ablation: a targeted clinical approach based on electrocardiographic and patient-specific criteria
Doctor F. Candanedo Ocana (Puerto Real, ES)
Abstract Slides Video
Presentation thumbnail
Feasibility of a transseptal approach for ablation of ventricular arrhythmias in patients after edge-to-edge mitral valve repair
Doctor S. Dittrich (Cologne, DE)
Abstract Slides Video
Presentation thumbnail
Isochronal late activation mapping during extra-stimulus pacing unmasks hidden zones of conduction slowing and functional conduction block
Mr A. Rashid (London, GB)
Abstract Slides Video
Presentation thumbnail
LAT velocity vectors: a novel tool for ventricular functional substrate characterization.
Doctor M. Parollo (Pisa, IT)
Abstract Slides Video
Presentation thumbnail
Sinus rhythm late activation zones as a target for improving ventricular tachycardia ablation outcomes
Doctor M. Sobral Domingues (Lisbon, PT)
Abstract Slides Video

Access the full session

Session thumbnail
Invasive treatment of ventricular arrhythmias

The Event

Event poster

EHRA 2025

30 March 2025 15:30 CET
You may be interested in
thumbnail
Congress Presentation
Ventricular tachycardia mapping and ablation using MIXture of well-established approaches. The MIX-VT study
thumbnail
Congress Session
Invasive management of ventricular arrhythmias
thumbnail
Congress Presentation
Integration of cardiac computed tomography with catheter ablation for ventricular tachycardia in patients with ischaemic heart disease

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources